BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical Research and Development - HT9425-23-S-SOC1
ID: HT9425-23-S-SOC1Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (AN12)

Original Source

https://sam.gov/opp/55f282f18379450f898b32ea949e433a/view
Timeline
    Description

    Special Notice DEPT OF DEFENSE is seeking proposals for extramural biomedical research and development. This opportunity is issued by the DEFENSE HEALTH AGENCY (DHA) under the BROAD AGENCY ANNOUNCEMENT (BAA) HT9425-23-S-SOC1. The purpose of this BAA is to solicit research and development ideas to advance the state-of-the-art or increase knowledge in the field. The projects funded under this BAA should focus on basic and applied research rather than the development of specific systems or hardware solutions. The research and development funding is expected to benefit both military and civilian medical practice and knowledge. Interested parties must submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If selected, the offeror will be invited to submit a full proposal or application through Grants.gov. The BAA is open for a 5-year period, from August 1, 2023, to July 31, 2028. The BAA with revised research areas of interest and General Submission Instructions can be found on Grants.gov using opportunity number HT9425-23-S-SOC1.

    Point(s) of Contact
    CDMRP Help Desk
    (301) 682-5507
    help@eBRAP.org
    Files
    Title
    Posted
    HT9425-23-S-SOC1_revised.pdf
    The United States Special Operations Command (USSOCOM) has issued a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development, with funding available from August 1, 2023, to July 31, 2028. The BAA seeks innovative research proposals focused on medical techniques and materials that support military and civilian healthcare, with increased individual project funding caps now at $5 million and project costs anticipated between $700,000 and $1.5 million. Eligible applicants include various organizations, and submissions must follow a two-step process involving a pre-proposal and, if invited, a full proposal through the eBRAP and Grants.gov systems.
    HT9425-23-S-SOC1-0001.pdf
    The United States Special Operations Command (USSOCOM) has released a Broad Agency Announcement (BAA) to fund extramural biomedical and human performance research from August 1, 2023, to July 31, 2028, with an increased project cost ceiling. The BAA seeks innovative research projects addressing health care needs relevant to military personnel, including damage control resuscitation, prolonged field care, human performance optimization, and canine medicine, emphasizing practicality in austere environments. Applicants must submit a pre-proposal via eBRAP, and those invited can then submit a full proposal through Grants.gov, with specific deadlines and requirements outlined in the announcement.
    HT9425-23-S-SOC1-0002.pdf
    The United States Special Operations Command is issuing a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development, which is open continuously from August 1, 2023, to July 31, 2028. The BAA aims to solicit proposals that advance military and civilian medical practices, with an increased individual project cost ceiling of $5 million, focusing on various research areas including human performance optimization, prolonged casualty care, and canine medicine. Interested organizations must adhere to specific submission guidelines outlined in associated documents and utilize platforms like eBRAP and Grants.gov for proposal submission.
    HT9425-23-S-SOC1.pdf
    The United States Special Operations Command (USSOCOM) has issued a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development, with a funding opportunity number HT9425-23-S-SOC1, continuously open from August 1, 2023, to July 31, 2028. The BAA invites proposals focused on various research areas to enhance military and civilian medical practices, emphasizing innovative technologies and improved training methods for Special Operations Forces. Key highlights include increased project funding caps, eligibility for various organizations, submission guidelines, and outlined evaluation criteria for proposals.
    HT9425-23-S-SOC1.pdf
    The United States Special Operations Command (USSOCOM) has issued a Broad Agency Announcement (BAA) for extramural biomedical and human performance research and development, open from August 1, 2023, through July 31, 2028. This BAA seeks innovative solutions targeting military and civilian medical practices, with a focus on areas such as canine combat casualty training, human performance optimization, and brain health, with project budgets not exceeding $5 million. Eligible applicants include various organizations, and proposals must go through a pre-proposal submission process via the electronic Biomedical Research Application Portal (eBRAP) before full application through Grants.gov.
    Similar Opportunities
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA
    Active
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE DEPT OF THE ARMY is seeking extramural research and development ideas for medical research. The USAMRDC aims to provide solutions to medical problems for the American Service Member and the general public. This BAA solicits basic and applied research projects to advance medical science and technology. The selection process is highly competitive, and submissions are accepted throughout a 5-year period. Pre-proposals must be submitted through the electronic Biomedical Research Application Portal (eBRAP), and invited full proposals must be submitted through Grants.gov.
    Biological Technologies
    Active
    Dept Of Defense
    The Defense Advanced Research Projects Agency (DARPA) is soliciting proposals for innovative research and development in Biological Technologies under the Broad Agency Announcement (BAA) HR001124S0034. This initiative aims to explore revolutionary ideas not currently addressed by existing programs, focusing on areas such as machine learning, human performance, materials technology, and biosecurity, all intended to enhance national security. Proposals will be evaluated based on scientific merit, relevance to DARPA's mission, and cost realism, with submissions accepted on a rolling basis until September 10, 2025. Interested parties can contact the BAA Coordinator at BTOBAA2024@darpa.mil for further information.
    Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) aimed at addressing public health threats such as chemical, biological, radiological, and nuclear (CBRN) incidents, as well as emerging infectious diseases and pandemic influenza. The initiative seeks to foster public-private partnerships to enhance the development and responsiveness of life-saving MCMs, emphasizing the importance of technological maturity, regulatory compliance, and manufacturing standards in the evaluation process. This opportunity is critical for strengthening national health security and improving preparedness for future public health emergencies, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties can direct inquiries to BARDA-BAA@hhs.gov for further information.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Active
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    Defense Sciences Office (DSO) Office-wide BAA
    Active
    Dept Of Defense
    The Defense Advanced Research Projects Agency (DARPA) is inviting proposals for its Defense Sciences Office (DSO) Office-wide Broad Agency Announcement (BAA), aimed at soliciting innovative research ideas that can lead to revolutionary advancements in national security applications. Proposals should focus on novel approaches rather than incremental improvements, covering key research areas such as Novel Materials & Structures, Sensing & Measurement, and Emerging Threats. This initiative is crucial for fostering advanced research that aligns with DARPA's mission to enhance national defense capabilities. Interested organizations can submit proposals until September 26, 2025, and should direct inquiries to the BAA Coordinator at HR001124S0039@darpa.mil.
    FY2025-2034 DTRA Chemical and Biological Technologies Fundamental Research Broad Agency Announcement
    Active
    Dept Of Defense
    The Defense Threat Reduction Agency (DTRA) is inviting proposals for the FY2025-2034 Chemical and Biological Technologies Fundamental Research Broad Agency Announcement (BAA), aimed at advancing research to counter Weapons of Mass Destruction (WMD). This opportunity emphasizes collaborative efforts from accredited universities, industrial entities, and not-for-profit research organizations, focusing on innovative solutions in chemical and biological defense, including detection, diagnostics, and countermeasures against C-WMD threats. The BAA is crucial for enhancing national security and promoting STEM education, with funding anticipated for approximately 30 awards each year, ranging from $25,000 to $1 million annually. Interested applicants must submit pre-application white papers by February 7, 2024, and can contact the DTRA RD-CB FRBAA Mailbox at dtra.belvoir.rd.mbx.rd-cb-frbaa25-34-ta1@mail.mil for further information.
    BROAD AGENCY ANNOUNCEMENT - BIOMEDICAL RESEARCH AND DIVING EQUIPMENT DEVELOPMENT
    Active
    Dept Of Defense
    The Department of Defense, specifically the Naval Sea Systems Command (NAVSEA), is soliciting proposals through a Broad Agency Announcement (BAA) for biomedical research and diving equipment development aimed at enhancing diver health, safety, and performance, as well as submarine escape and rescue capabilities. The primary objectives include improving diving equipment and biomedical aspects related to diver operations, with a focus on areas such as breathing gas supply, human performance, environmental protection, decompression, and submarine rescue strategies. This initiative is critical for advancing the safety and effectiveness of Navy personnel during underwater operations, with contracts typically averaging around $300,000 annually. Interested parties must submit pre-proposals by November 30, 2024, for FY26 funding, with full proposals due by February 28, 2025. For further inquiries, contact Lisa Grayum at lisa.m.grayum.civ@us.navy.mil or Daniel Kough at daniel.w.kough2.civ@us.navy.mil.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is soliciting proposals through the FY25 Broad Agency Announcement (BAA) aimed at advancing regulatory science and innovation. This opportunity invites organizations, particularly small businesses, to submit research and development proposals that address critical areas such as alternative drug development methods, advanced manufacturing technologies, and predictive toxicology, with a strong emphasis on including diverse populations in research. Proposals must be submitted by February 24, 2025, and will undergo a two-tier evaluation process, with the potential for multiple contracts awarded based on proposal quality and funding availability. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    Strategic Technology Office-wide Broad Agency Announcement
    Active
    Dept Of Defense
    The Defense Advanced Research Projects Agency (DARPA) is inviting proposals for its Strategic Technology Office-wide Broad Agency Announcement (BAA) HR001125S0001, aimed at funding innovative research that leads to revolutionary advances in technology for national security. Proposals should focus on disruptive technologies across various domains, including artificial intelligence, advanced computing, and robotics, while avoiding evolutionary improvements to existing practices. This initiative is critical for developing new capabilities that enhance the U.S. military's operational effectiveness and adaptability in complex environments. Interested organizations, including small and minority-owned businesses, must submit their proposals by October 31, 2025, and are encouraged to contact the BAA Coordinator at HR001125S0001@darpa.mil for further information.
    BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Office of Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003, which focuses on innovative medical countermeasures (MCMs) to enhance public health preparedness against various threats, including infectious diseases and chemical agents. The initiative invites submissions across multiple Areas of Interest (AOIs), including but not limited to vaccine innovations, diagnostic technologies, and therapeutic solutions for acute radiation syndrome and chemical threats. This opportunity is critical for advancing biomedical research and developing effective responses to health emergencies, with multiple awards anticipated based on scientific merit and funding availability. Interested parties must register on SAM.gov and submit their abstracts by specified deadlines, with key submission dates ranging from March 15, 2024, to May 31, 2024, depending on the AOI. For further inquiries, respondents can contact Aarati Singal or Lara Emmons at DRIVeAcquisitions@hhs.gov.